Progyny expects Q2 results above previous forecast; shares gain

Shares of fertility benefits management firm Progyny PGNY.O rise 11% to $23.81

Co says it expects Q2 revenue, adj net income and adj core profit to be slightly better than the ranges it had forecast previously

CEO Pete Anevski says member activity has paced favorably as compared to outlook

Co previously expected Q2 revenue between $310 million and $325 million, net income between $11.5 million and $14.5 million and adjusted core profit between $49 million and $53 million

Co will report results on August 7

Adds it has entered into a revolving credit facility for up to $200 million, with a maturity date of July 1, 2030

Stock up 36% YTD